A Study to Evaluate the Effects of a Dietary Supplement on Children's Health and Development Outcomes.

Completed · Not applicable · Has a placebo group

Conditions studied: Height, Cognitive Function, Weight Gain

In brief

A 6-month virtual two-armed randomized double-blind placebo-controlled clinical trial. Participants will take NuBest Tall Growth Protein Powder or a placebo daily. Parents will complete questionnaires at baseline and monthly, and children will undergo cognitive assessments and height/weight measurements at specified intervals.

Key facts

Study ID

NCT06704178

Run by

NuBest

People needed

60

Starts

2024-06-12

Expected to finish

2025-02-16

Last updated by the study team

2025-07-24

Who can join

Age: 10 and older, up to 16. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Interested in their child trialing a dietary supplement designed to improve overall health outcomes in children including height, maintenance of a healthy weight, cognitive function, immune function, and energy levels.
• Willing to refrain from giving their child any vitamins, minerals, or herbal supplements of any kind for the duration of the study.
• Parents willing to weigh and measure the height of their child throughout the study.
• Generally healthy - do not have any uncontrolled chronic disease.

You may not qualify if…

• Any child with a history of endocrine disorder, heart disease, lung disease, kidney disease, digestive disease, or skeletal dysplasia.
• Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
• Is undergoing or planning to undergo significant medical procedures in the next six months.
• A history of severe allergic reactions, including but not limited to any of the product's ingredients.
• Any child with a dairy allergy or lactose intolerance.
• Has undergone any surgeries or invasive treatments in the last six months.
• Has had any major illness in the last three months.
• Having any planned invasive medical procedures during the study period.
• Currently participating in any other clinical study.
• Unwilling to follow the study protocol.
• Any child diagnosed with attention-deficit disorder (ADD) or attention-deficit hyperactivity disorder (ADHD).
• Any child currently taking or have taken in the last 3 months any prescription medication targeting ADD or ADHD (such as Adderall, Concerta, Focalin, Evekeo, or Ritalin).
• Any child that is a 'fussy' eater or who the parent suspects may not tolerate consuming the test product daily for six months.

Where it is running

• Citruslabs — Santa Monica, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.